Astrin Biosciences has filed a notice of an exempt offering of securities to raise $22,948,872.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Astrin Biosciences is raising up to $22,948,872.00 in new funding. Sources indicate that as part of senior management President, Jayant Parthasarathy played a key role…